Compare Covalon Technologies Ltd. with Similar Stocks
Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of 5.76% and Operating profit at 15.64% over the last 5 years
2
With a growth in Net Profit of 772.13%, the company declared Very Positive results in Mar 26
3
With ROE of 3.90%, it has a expensive valuation with a 1.87 Price to Book Value
4
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
30.12%
0%
30.12%
6 Months
26.32%
0%
26.32%
1 Year
-11.84%
0%
-11.84%
2 Years
0%
0%
0.0%
3 Years
13.09%
0%
13.09%
4 Years
-15.95%
0%
-15.95%
5 Years
53.19%
0%
53.19%
Covalon Technologies Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
5.24%
EBIT Growth (5y)
17.84%
EBIT to Interest (avg)
-2.65
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.56
Sales to Capital Employed (avg)
1.17
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.49%
ROE (avg)
2.47%
Valuation key factors
Factor
Value
P/E Ratio
38
Industry P/E
Price to Book Value
2.14
EV to EBIT
38.35
EV to EBITDA
20.90
EV to Capital Employed
3.71
EV to Sales
1.34
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
9.67%
ROE (Latest)
5.68%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
8.70
6.90
26.09%
Operating Profit (PBDIT) excl Other Income
1.20
0.30
300.00%
Interest
0.00
0.00
Exceptional Items
0.10
-0.10
200.00%
Consolidate Net Profit
1.10
0.10
1,000.00%
Operating Profit Margin (Excl OI)
105.40%
7.60%
9.78%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 26.09% vs -20.69% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 1,000.00% vs -75.00% in Dec 2025
Annual Results Snapshot (Consolidated) - Sep'25
Sep'25
Sep'24
Change(%)
Net Sales
32.80
31.20
5.13%
Operating Profit (PBDIT) excl Other Income
2.70
3.10
-12.90%
Interest
0.00
0.10
-100.00%
Exceptional Items
-0.10
0.60
-116.67%
Consolidate Net Profit
2.10
2.70
-22.22%
Operating Profit Margin (Excl OI)
53.70%
69.00%
-1.53%
USD in Million.
Net Sales
YoY Growth in year ended Sep 2025 is 5.13% vs 17.29% in Sep 2024
Consolidated Net Profit
YoY Growth in year ended Sep 2025 is -22.22% vs 160.00% in Sep 2024
About Covalon Technologies Ltd. 
Covalon Technologies Ltd.
Pharmaceuticals & Biotechnology
Covalon Technologies Ltd. is a researcher, developer, manufacturer and marketer of medical products that manage patient outcomes and save lives in the areas of wound care, infection management and surgical procedures. The Company offers platform technologies: Collagen matrix; Antimicrobial silicone adhesive and Medical coating technology. The collagen matrix platform is used to manufacture products that treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns. The antimicrobial silicone adhesive platform is the basis for a range of pre-surgical, post surgical and vascular access products that are designed to kill any bacteria or yeast that comes into contact with the antimicrobial silicone. The coating technology is a grafting from process, which utilizes photo-polymerization to create active grafting sites.
Company Coordinates 
Company Details
1660 Tech Ave Unit 5 , MISSISSAUGA ON : L4W 5S7
Registrar Details






